BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1899726)

  • 1. Trypanosoma cruzi: properties of a clone isolated from CL strain.
    Lima MT; Jansen AM; Rondinelli E; Gattass CR
    Parasitol Res; 1991; 77(1):77-81. PubMed ID: 1899726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative tissue parasitism in mice injected with a noninfective clone of Trypanosoma cruzi.
    Lima MT; Lenzi HL; Gattass CR
    Parasitol Res; 1995; 81(1):6-12. PubMed ID: 7724515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations.
    Paláu MT; Mejía AJ; Vergara U; Zúñiga CA
    Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):543-8. PubMed ID: 12937771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: both chemically induced and triatomine-derived metacyclic trypomastigotes cause the same immunological disturbances in the infected mammalian host.
    Lopes MF; Cunha JM; Bezerra FL; Gonzalez MS; Gomes JE; Lapa e Silva JR; Garcia ES; Dos Reis GA
    Exp Parasitol; 1995 Mar; 80(2):194-204. PubMed ID: 7895831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of exposure to non-virulent Trypanosoma cruzi clones on the course of subsequent infections with highly virulent clones in mice.
    Lauria-Pires L; Teixeira AR
    J Comp Pathol; 1997 Aug; 117(2):119-26. PubMed ID: 9352436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of high numbers of blood trypomastigotes of Trypanosoma cruzi in nude rats.
    Schaub GA; Hölscher C; Mossmann H
    Parasitol Res; 2001 Mar; 87(3):245-7. PubMed ID: 11293574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of infection in mice inoculated by the oral route with different developmental forms of Trypanosoma cruzi I and II.
    Dias GB; Gruendling AP; Araújo SM; Gomes ML; Toledo MJ
    Exp Parasitol; 2013 Nov; 135(3):511-7. PubMed ID: 23994765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vertical transmission of Trypanosoma cruzi in Wistar rats during the acute phase of infection].
    Moreno EA; Rivera IM; Moreno SC; Alarcón ME; Lugo-Yarbuh A
    Invest Clin; 2003 Sep; 44(3):241-54. PubMed ID: 14552062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.
    Antúnez MI; Cardoni RL
    Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C; Cortez M; Ferreira D; Yoshida N
    Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence.
    Rowland E; Luo H; McCormick T
    J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection by the Sylvio X10/4 clone of Trypanosoma cruzi: relevance of a low-virulence model of Chagas' disease.
    Marinho CR; Nuñez-Apaza LN; Bortoluci KR; Bombeiro AL; Bucci DZ; Grisotto MG; Sardinha LR; Jorquera CE; Lira S; Lima MR; Alvarez JM
    Microbes Infect; 2009 Nov; 11(13):1037-45. PubMed ID: 19660570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against the flagellar fraction of epimastigotes of Trypanosoma cruzi: immunoprotection against metacyclic trypomastigotes obtained by immunization of mice with an affinity-purified antigen.
    Ruiz AM; Esteva M; Subias E; Moreno M; Rosenstein de Campanini A; Velazquez E; Segura EL
    Mol Biochem Parasitol; 1990 Feb; 39(1):117-25. PubMed ID: 2106075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of specific antibodies in Trypanosoma cruzi infections.
    Krettli AU; Brener Z
    J Immunol; 1976 Mar; 116(3):755-60. PubMed ID: 815433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain specific protective immunity against Trypanosoma cruzi.
    Kloetzel JK; Lafaille JJ
    J Parasitol; 1983 Apr; 69(2):267-70. PubMed ID: 6406657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: Impact of dual-clone infections on parasite biological properties in BALB/c mice.
    Martins HR; Toledo MJ; Veloso VM; Carneiro CM; Machado-Coelho GL; Tafuri WL; Bahia MT; Valadares HM; Macedo AM; Lana M
    Exp Parasitol; 2006 Apr; 112(4):237-46. PubMed ID: 16406355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.
    Frank FM; Petray PB; Cazorla SI; Muñoz MC; Corral RS; Malchiodi EL
    Vaccine; 2003 Dec; 22(1):77-86. PubMed ID: 14604574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi surface molecule gp90 downregulates invasion of gastric mucosal epithelium in orally infected mice.
    Cortez M; Silva MR; Neira I; Ferreira D; Sasso GR; Luquetti AO; Rassi A; Yoshida N
    Microbes Infect; 2006 Jan; 8(1):36-44. PubMed ID: 16153873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of clones of the Brazil strain of Trypanosoma cruzi.
    Murfin DJ; Choromanski L; Kuhn RE
    J Parasitol; 1985 Oct; 71(5):525-9. PubMed ID: 3932632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.